Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.700 GeneticVariation group UNIPROT
Entrez Id: 238
Gene Symbol: ALK
ALK
0.610 CausalMutation group CGI
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CGI
Entrez Id: 3417
Gene Symbol: IDH1
IDH1
0.500 CausalMutation group CGI
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.500 CausalMutation group CGI
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.500 CausalMutation group CGI
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.480 CausalMutation group CGI
Entrez Id: 324
Gene Symbol: APC
APC
0.160 Biomarker group HPO
Entrez Id: 5426
Gene Symbol: POLE
POLE
0.120 Biomarker group HPO
Entrez Id: 2313
Gene Symbol: FLI1
FLI1
0.120 Biomarker group HPO
Entrez Id: 5424
Gene Symbol: POLD1
POLD1
0.100 Biomarker group HPO
Entrez Id: 348654
Gene Symbol: GEN1
GEN1
0.010 Biomarker group BEFREE <b>Background:</b> Previous studies showed that confocal laser endomicroscopy (CLE) images of brain tumors acquired by a first-generation (Gen1) CLE system using fluorescein sodium (FNa) contrast yielded a diagnostic accuracy similar to frozen surgical sections and histologic analysis. 31334106 2019
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.500 GeneticVariation group BEFREE <b>Purpose:</b> The epidermal growth factor receptor variant III (<i>EGFRvIII</i>) mutation has been considered a driver mutation and therapeutic target in glioblastoma, the most common and aggressive brain cancer. 28428190 2017
Entrez Id: 4255
Gene Symbol: MGMT
MGMT
0.400 Biomarker group BEFREE (2) Persistence of prenatal MGMT deficiency into postnatal life in a sub-population of individuals may increase brain tumor risk. 17500046 2007
Entrez Id: 1326
Gene Symbol: MAP3K8
MAP3K8
0.010 AlteredExpression group BEFREE 11 (an EST) was expressed only in brain tumors but not in normal brain by Northern analysis (message size 1.5 kb) and RT-PCR. 11172594 2001
Entrez Id: 6783
Gene Symbol: SULT1E1
SULT1E1
0.010 AlteredExpression group BEFREE 11 (an EST) was expressed only in brain tumors but not in normal brain by Northern analysis (message size 1.5 kb) and RT-PCR. 11172594 2001
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.700 GeneticVariation group BEFREE Brain tumors were associated with missense TP53 mutations located in the DNA-binding loop that contact the minor groove of DNA (P = 0.01), whereas adrenal gland carcinomas were associated with missense mutations located in the loops opposing the protein-DNA contact surface (P = 0.003). 14583457 2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.400 Biomarker group LHGDN Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. 16036113 2005
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.700 GeneticVariation group BEFREE Brain tumors have previously been associated with the Li-Fraumeni syndrome that often is caused by p53 germ line mutations. 16172235 2005
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.500 GeneticVariation group BEFREE Brain tumor response could be evaluated by MRI in these patients; EGFR gene analyses were also available. 16510849 2006
Entrez Id: 5921
Gene Symbol: RASA1
RASA1
0.010 GeneticVariation group BEFREE Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. 1662505 1991
Entrez Id: 8842
Gene Symbol: PROM1
PROM1
0.100 Biomarker group BEFREE Brain tumor xenografts initiated from glioblastoma (GBM) CD133(+) tumor stem-like cells (TSCs) are composed of TSC and non-TSC subpopulations, simulating the phenotypic heterogeneity of GBMs in situ. 22431923 2012
Entrez Id: 347487
Gene Symbol: CXorf66
CXorf66
0.010 GeneticVariation group BEFREE Brain cancer in female patients exhibited elevated copy numbers of the SGPX gene. 24709545 2014
Entrez Id: 8028
Gene Symbol: MLLT10
MLLT10
0.010 GeneticVariation group BEFREE Brain tumor risk according to germ-line variation in the MLLT10 locus. 24755950 2015
Entrez Id: 7037
Gene Symbol: TFRC
TFRC
0.060 Biomarker group BEFREE Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. 27374198 2016